A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

SIMPLE SUMMARY: AML is a common form of blood cancer in adults. This study was undertaken to evaluate if AML patients who have failed the available standard treatment options could tolerate and potentially benefit from a new form of therapy. This new therapy activates patients’ own immune system aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Uckun, Fatih M., Lin, Tara L., Mims, Alice S., Patel, Prapti, Lee, Cynthia, Shahidzadeh, Anoush, Shami, Paul J., Cull, Elizabeth, Cogle, Christopher R., Watts, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394899/
https://www.ncbi.nlm.nih.gov/pubmed/34439266
http://dx.doi.org/10.3390/cancers13164113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394899/
https://www.ncbi.nlm.nih.gov/pubmed/34439266
http://dx.doi.org/10.3390/cancers13164113

Ejemplares similares